Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $238.18 | 7 | 89.6% |
| Education | $27.65 | 2 | 10.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith & Nephew, Inc. | $118.72 | 1 | $0 (2017) |
| AbbVie, Inc. | $43.09 | 3 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $27.65 | 2 | $0 (2018) |
| CooperSurgical, Inc. | $27.06 | 1 | $0 (2022) |
| PFIZER INC. | $25.70 | 1 | $0 (2017) |
| Daiichi Sankyo Inc. | $23.61 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $27.06 | 1 | CooperSurgical, Inc. ($27.06) |
| 2019 | $27.70 | 2 | AbbVie, Inc. ($27.70) |
| 2018 | $53.09 | 3 | Daiichi Sankyo Inc. ($23.61) |
| 2017 | $157.98 | 3 | Smith & Nephew, Inc. ($118.72) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2022 | CooperSurgical, Inc. | Summit Doppler (Device) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Devices | ||||||
| 05/21/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Endocrinology | ||||||
| 03/18/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Endocrinology | ||||||
| 11/20/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Endocrinology | ||||||
| 09/17/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Anemia | ||||||
| 05/15/2018 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Education | In-kind items and services | $14.09 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/17/2017 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Education | In-kind items and services | $13.56 | General |
| Category: HYDROXYPROGESTERONE CAPROATE PROGESTERONE CONGENERS | ||||||
| 05/17/2017 | Smith & Nephew, Inc. | PICO (Device) | Food and Beverage | In-kind items and services | $118.72 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 03/20/2017 | PFIZER INC. | DYLOJECT (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: INFLAMMATION;PAIN | ||||||
About Dr. Jeffrey Wanerman, M.D
Dr. Jeffrey Wanerman, M.D is a Obstetrics & Gynecology healthcare provider based in Amityville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235230004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Wanerman, M.D has received a total of $265.83 in payments from pharmaceutical and medical device companies, with $27.06 received in 2022. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($238.18).
Practice Information
- Specialty Obstetrics & Gynecology
- Location Amityville, NY
- Active Since 09/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1235230004
Products in Payments
- PICO (Device) $118.72
- Orilissa (Drug) $43.09
- MAKENA (Drug) $27.65
- Summit Doppler (Device) $27.06
- DYLOJECT (Drug) $25.70
- INJECTAFER (Drug) $23.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.